Persistent pain facilitates response to morphine reward by downregulation of central amygdala GABAergic function

Neuropsychopharmacology

Volumn 39, Issue 9, 2014, Pages 2263-2271

  Zhang, Zhi ^a,b   Tao, Wenjuan ^b   Hou, Yuan Yuan ^a   Wang, Wei ^a   Lu, Yun Gang ^c   Pan, Zhizhong Z ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; MORPHINE; 4 AMINOBUTYRIC ACID; FREUND ADJUVANT; INTERLEUKIN 1 RECEPTOR; MEMBRANE PROTEIN; NARCOTIC ANALGESIC AGENT; TIRAP PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CENTRAL NUCLEUS (AMYGDALA); CHRONIC PAIN; CONDITIONED PLACE PREFERENCE TEST; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; GABAERGIC TRANSMISSION; MALE; NERVE CELL; NONHUMAN; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; PLACE PREFERENCE; PRIORITY JOURNAL; RANDOMIZATION; RAT; REWARD; ANIMAL; CONDITIONING; DEPTH PERCEPTION; DISEASE MODEL; DRUG EFFECTS; HINDLIMB; HYPERALGESIA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; CENTRAL AMYGDALOID NUCLEUS; CHRONIC PAIN; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOWN-REGULATION; FREUND'S ADJUVANT; GAMMA-AMINOBUTYRIC ACID; HINDLIMB; HYPERALGESIA; MEMBRANE GLYCOPROTEINS; MORPHINE; NEURONS; RANDOM ALLOCATION; RATS, WISTAR; RECEPTORS, GABA-A; RECEPTORS, INTERLEUKIN-1; REWARD; SPACE PERCEPTION; SYNAPTIC TRANSMISSION;

EID: 84904461489     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.77     Document Type: Article

References (62)

1. Ballantyne JC, LaForge KS (2007). Opioid dependence and addiction during opioid treatment of chronic pain. Pain 129: 235-255.
2. Banta-Green CJ, Von Korff M, Sullivan MD, Merrill JO, Doyle SR, Saunders K (2010). The prescribed opioids difficulties scale: a patient-centered assessment of problems and concerns. Clin J Pain 26: 489-497.
3. Baxter MG, Murray EA (2002). The amygdala and reward. Nat Rev Neurosci 3: 563-573.
4. Bhargava HN (1994). Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and selfadministrative behavior. Pharmacol Rev 46: 293-324.
5. Bie B, Wang Y, Cai YQ, Zhang Z, Hou YY, Pan ZZ (2012). Upregulation of nerve growth factor in central amygdala increases sensitivity to opioid reward. Neuropsychopharmacol 37: 2780-2788.
6. Bie B, Zhu W, Pan ZZ (2009). Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses. J Pharmacol Exp Ther 329: 290-296.
7. Boscarino JA, Rukstalis M, Hoffman SN, Han JJ, Erlich PM, Gerhard GS et al (2010). Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction 105: 1776-1782.
8. Bourgeais L, Gauriau C, Bernard JF (2001). Projections from the nociceptive area of the central nucleus of the amygdala to the forebrain: a PHA-L study in the rat. Eur J Neurosci 14: 229-255.
9. Cahill CM, Xue L, Grenier P, Magnussen C, Lecour S, Olmstead MC (2013). Changes in morphine reward in a model of neuropathic pain. Behav Pharmacol 24: 207-213.
10. Colpaert FC, Tarayre JP, Alliaga M, Bruins Slot LA, Attal N, Koek W (2001). Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats. Pain 91: 33-45.
11. Compton WM, Volkow ND (2006). Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 81: 103-107.
12. Edlund MJ, Martin BC, Fan MY, Devries A, Braden JB, Sullivan MD (2010). Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend 112: 90-98.
13. Ehrlich I, Humeau Y, Grenier F, Ciocchi S, Herry C, Luthi A (2009). Amygdala inhibitory circuits and the control of fear memory. Neuron 62: 757-771.
14. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, Robbins TW (1999). Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann N Y Acad Sci 877: 412-438.
15. Fields HL (2004). State-dependent opioid control of pain. Nat Rev Neurosci 5: 565-575.
16. Fields HL (2000). Pain modulation: expectation, opioid analgesia and virtual pain. Prog Brain Res 122: 245-253.
17. Gonzales C, Chesselet MF (1990). Amygdalonigral pathway: an anterograde study in the rat with Phaseolus vulgaris leucoagglutinin (PHA-L). J Comp Neurol 297: 182-200.
18. Gottfried JA, O'Doherty J, Dolan RJ (2003). Encoding predictive reward value in human amygdala and orbitofrontal cortex. Science 301: 1104-1107.
19. Haubensak W, Kunwar PS, Cai H, Ciocchi S, Wall NR, Ponnusamy R et al (2010). Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 468: 270-276.
20. Hojsted J, Sjogren P (2007). Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 11: 490-518.
21. Huyser BA, Parker JC (1999). Negative affect and pain in arthritis. Rheum Dis Clin North Am 25: 105-121, vi.
22. Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J et al (2004). A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 24: 7353-7365.
23. Kahan M, Srivastava A, Wilson L, Gourlay D, Midmer D (2006). Misuse of and dependence on opioids: study of chronic pain patients. Can Fam Physician 52: 1081-1087.
24. King T, Vera-Portocarrero L, Gutierrez T, Vanderah TW, Dussor G, Lai J et al (2009). Unmasking the tonic-aversive state in neuropathic pain. Nat Neurosci 12: 1364-1366.
25. Koob GF (1999). Stress, corticotropin-releasing factor, and drug addiction. Ann N Y Acad Sci 897: 27-45.
26. Koob GF, Volkow ND (2010). Neurocircuitry of addiction. Neuropsychopharmacol 35: 217-238.
27. Kreibich AS, Briand L, Cleck JN, Ecke L, Rice KC, Blendy JA (2009). Stress-induced potentiation of cocaine reward: a role for CRF R1 and CREB. Neuropsychopharmacol 34: 2609-2617.
28. Kupers R, Gybels J (1995). The consumption of fentanyl is increased in rats with nociceptive but not with neuropathic pain. Pain 60: 137-141.
29. Le Merrer J, Becker JA, Befort K, Kieffer BL (2009). Reward processing by the opioid system in the brain. Physiol Rev 89: 1379-1412.
30. Leknes S, Tracey I (2008). A common neurobiology for pain and pleasure. Nat Rev Neurosci 9: 314-320.
31. Leshan RL, Opland DM, Louis GW, Leinninger GM, Patterson CM, Rhodes CJ et al (2010). Ventral tegmental area leptin receptor neurons specifically project to and regulate cocaine- and amphetamine-regulated transcript neurons of the extended central amygdala. J Neurosci 30: 5713-5723.
32. Lu L, Shepard JD, Hall FS, Shaham Y (2003). Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci Biobehav Rev 27: 457-491.
33. Luo AH, Tahsili-Fahadan P, Wise RA, Lupica CR, Aston-Jones G (2011). Linking context with reward: a functional circuit from hippocampal CA3 to ventral tegmental area. Science 333: 353-357.
34. Luscher C, Malenka RC (2011). Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69: 650-663.
35. Maren S, Phan KL, Liberzon I (2013). The contextual brain: implications for fear conditioning, extinction and psychopathology. Nat Rev Neurosci 14: 417-428.
36. Martin TJ, Kim SA, Buechler NL, Porreca F, Eisenach JC (2007). Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics. Anesthesiology 106: 312-322.
37. McCabe SE, Cranford JA, West BT (2008). Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict Behav 33: 1297-1305.
38. McDonald AJ (1982). Cytoarchitecture of the central amygdaloid nucleus of the rat. J Comp Neurol 208: 401-418.
39. McWilliams LA, Cox BJ, Enns MW (2003). Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain 106: 127-133.
40. Murray EA (2007). The amygdala, reward and emotion. Trends Cogn Sci 11: 489-497.
41. Narita M, Kishimoto Y, Ise Y, Yajima Y, Misawa K, Suzuki T (2005). Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state. Neuropsychopharmacol 30: 111-118.
42. Neugebauer V, Li W, Bird GC, Han JS (2004). The amygdala and persistent pain. Neuroscientist 10: 221-234.
43. Ozaki S, Narita M, Iino M, Miyoshi K, Suzuki T (2003). Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2. Neuroscience 116: 89-97.
44. Pedersen LH, Scheel-Kruger J, Blackburn-Munro G (2007). Amygdala GABA-A receptor involvement in mediating sensory- discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury. Pain 127: 17-26.
45. Pohl M, Smith L (2012). Chronic pain and addiction: challenging co-occurring disorders. J Psychoactive Drugs 44: 119-124.
46. Reger ML, Poulos AM, Buen F, Giza CC, Hovda DA, Fanselow MS (2012). Concussive brain injury enhances fear learning and excitatory processes in the amygdala. Biol Psychiatry 71: 335-343.
47. Ren W, Neugebauer V (2010). Pain-related increase of excitatory transmission and decrease of inhibitory transmission in the central nucleus of the amygdala are mediated by mGluR1. Mol Pain 6: 93.
48. Rodriguez Manzanares PA, Isoardi NA, Carrer HF, Molina VA (2005). Previous stress facilitates fear memory, attenuates GABAergic inhibition, and increases synaptic plasticity in the rat basolateral amygdala. J Neurosci 25: 8725-8734.
49. Russo SJ, Dietz DM, Dumitriu D, Morrison JH, Malenka RC, Nestler EJ (2010). The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci 33: 267-276.
50. Santos M, D'Amico D, Spadoni O, Amador-Arjona A, Stork O, Dierssen M (2013). Hippocampal hyperexcitability underlies enhanced fear memories in TgNTRK3, a panic disorder mouse model. J Neurosci 33: 15259-15271.
51. Soghomonian JJ, Martin DL (1998). Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci 19: 500-505.
52. Sufka KJ (1994). Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain 58: 355-366.
53. Sullivan M, Ferrell B (2005). Ethical challenges in the management of chronic nonmalignant pain: negotiating through the cloud of doubt. J Pain 6: 2-9.
54. Tian N, Petersen C, Kash S, Baekkeskov S, Copenhagen D, Nicoll R (1999). The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. Proc Natl Acad Sci USA 96: 12911-12916.
55. Tzschentke TM (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12: 227-462.
56. Urban R, Scherrer G, Goulding EH, Tecott LH, Basbaum AI (2011). Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury-induced mechanical hypersensitivity. Pain 152: 990-1000.
57. Wilensky AE, Schafe GE, Kristensen MP, LeDoux JE (2006). Rethinking the fear circuit: the central nucleus of the amygdala is required for the acquisition, consolidation, and expression of Pavlovian fear conditioning. J Neurosci 26: 12387-12396.
58. Wilson KG, Mikail SF, D'Eon JL, Minns JE (2001). Alternative diagnostic criteria for major depressive disorder in patients with chronic pain. Pain 91: 227-234.
59. Woolf CJ, Hashmi M (2004). Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids. Curr Opin Investig Drugs 5: 61-66.
60. Zhang Z, Cai YQ, Zou F, Bie B, Pan ZZ (2011). Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med 17: 1448-1455.
61. Zhang Z, Pan ZZ (2012). Signaling cascades for delta-opioid receptor-mediated inhibition of GABA synaptic transmission and behavioral antinociception. Mol Pharmacol 81: 375-383.
62. Zhu W, Bie B, Pan ZZ (2007). Involvement of non-NMDA glutamate receptors in central amygdala in synaptic actions of ethanol and ethanol-induced reward behavior. J Neurosci 27: 289-298.